Professor, Pediatrics, Boston University School of Medicine
Neonat/Perinatology
Dr. Mark H. Mirochnick, MD
|
|
Give Review
Mark Mirochnick is an expert in the field of Neonat/Perinatology. He studied medicine at University of Vermont College of Medicine. Mark Mirochnick is a published doctor and has 78 publications published. The lastest was: 'Blood pressure in children exposed prenatally to cocaine.'
Publications
- Maraviroc Pharmacokinetics in HIV-1 Infected Pregnant Women.
- Alteration in cytochrome P450 3A4 activity as measured by a urine cortisol assay in HIV-1-infected pregnant women and relationship to antiretroviral pharmacokinetics.
- Impact of body weight and missed doses on lopinavir concentrations with standard and increased lopinavir/ritonavir doses during late pregnancy.
- Can traditional birth attendants be trained to accurately identify septic infants, initiate antibiotics, and refer in a rural African setting?
- Raltegravir Pharmacokinetics in Neonates Following Maternal Dosing.
- Raltegravir Pharmacokinetics during Pregnancy.
- Pharmacokinetics of an Increased Atazanavir Dose with and without Tenofovir During the Third Trimester of Pregnancy.
- Reduced indinavir exposure during pregnancy.
- Pharmacotherapy of perinatal HIV.
- Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.
- Lopinavir protein binding in HIV-1-infected pregnant women.
- Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartum.
- Oseltamivir pharmacokinetics in pregnancy: a commentary.
- Stability of chloroquine in an extemporaneously prepared suspension stored at three temperatures.
- Nevirapine plasma concentrations in premature infants exposed to single-dose nevirapine for prevention of mother-to-child transmission of HIV-1.
- Zidovudine, lamivudine, and nelfinavir concentrations in amniotic fluid and maternal serum.
- A comparison of 3 regimens to prevent nevirapine resistance mutations in HIV-infected pregnant women receiving a single intrapartum dose of nevirapine.
- Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Stu...
- Blood pressure in children exposed prenatally to cocaine.
- Elevated plasma norepinephrine after in utero exposure to cocaine and marijuana.
- Early postpartum pharmacokinetics of lopinavir initiated intrapartum in Thai women.
- Circulating catecholamine concentrations in cocaine-exposed neonates: a pilot study.
- Late dose-response effects of prenatal cocaine exposure on newborn neurobehavioral performance.
- Dapsone penetrates cerebrospinal fluid during Pneumocystis carinii pneumonia prophylaxis.
- Effect of training traditional birth attendants on neonatal mortality (Lufwanyama Neonatal Survival Project): randomised controlled study.
- Cocaine absorption after application of a viscous cocaine-containing TAC solution.
- Cerebrospinal fluid monoamine precursors and metabolites in human neonates following in utero cocaine exposure: a preliminary study.
- Pharmacokinetics of dapsone administered daily and weekly in human immunodeficiency virus-infected children.
- Bioequivalence of a propylene glycol-based liquid dapsone preparation and dapsone tablets.
- Antiretroviral pharmacology in pregnant women and their newborns.
- Predose infant nevirapine concentration with the two-dose intrapartum neonatal nevirapine regimen: association with timing of maternal intrapartum nevirapine dose.
- Antiretroviral concentrations in breast-feeding infants of mothers receiving highly active antiretroviral therapy.
- Renal response to furosemide in very low birth weight infants during chronic administration.
- Fetal liver ultrasound measurements in isoimmunized pregnancies.
- Furosemide pharmacokinetics in very low birth weight infants.
- Qualitative amniotic fluid volume versus amniocentesis in predicting infection in preterm premature rupture of the membranes.
- Fetal biophysical profile versus amniocentesis in predicting infection in preterm premature rupture of the membranes.
- Zidovudine pharmacokinetics in premature infants exposed to human immunodeficiency virus.
- Nevirapine concentrations in newborns receiving an extended prophylactic regimen.
- Safety and pharmacokinetics of nelfinavir coadministered with zidovudine and lamivudine in infants during the first 6 weeks of life.
- Pharmacokinetics of dapsone in children.
- Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team.
- Nevirapine: pharmacokinetic considerations in children and pregnant women.
- Antiretroviral concentrations in breast-feeding infants of women in Botswana receiving antiretroviral treatment.
- Pharmacokinetics and tolerance of zidovudine in preterm infants.
- Pharmacokinetics of oral zidovudine administered during labour: a preliminary study.
- Antiretroviral pharmacology: special issues regarding pregnant women and neonates.
- Persistence of nevirapine exposure during the postpartum period after intrapartum single-dose nevirapine in addition to zidovudine prophylaxis for the prevention of mo...
- Lopinavir exposure with an increased dose during pregnancy.
- Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants.
- Atazanavir pharmacokinetics with and without tenofovir during pregnancy.
- Nevirapine pharmacokinetics in pregnant women and in their infants after in utero exposure.
- Dapsone for prevention of Pneumocystis pneumonia in children with acquired immunodeficiency syndrome.
- Relation between meconium concentration of the cocaine metabolite benzoylecgonine and fetal growth.
- Pharmacokinetics of zidovudine in infants: a population analysis across studies.
- Concentrations of protease inhibitors in cord blood after in utero exposure.
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomi...
- Association of cord blood nevirapine concentration with reported timing of dose and HIV-1 transmission.
- Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up...
- Pharmacokinetics of antiretrovirals in pregnant women.
- Population pharmacokinetics of dapsone in children with human immunodeficiency virus infection.
- A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006).
- Pharmacokinetics and safety of nelfinavir when used in combination with zidovudine and lamivudine in HIV-infected pregnant women: Pediatric AIDS Clinical Trials Group ...
- Phase I evaluation of zidovudine administered to infants exposed at birth to the human immunodeficiency virus.
- Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).
- Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics.
- Potential confounding of the association between exposure to nucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants.
- High failure rate of dapsone and pentamidine as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected children.
- Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
- Nelfinavir and Lamivudine pharmacokinetics during the first two weeks of life.
- Lopinavir tablet pharmacokinetics with an increased dose during pregnancy.
- Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants.
- Level of in utero cocaine exposure and neonatal ultrasound findings.
- Reduced lopinavir exposure during pregnancy.
- Impact of pregnancy on abacavir pharmacokinetics.
- Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.
- Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women.
Schools
University Of Vermont College Of Medicine
Boston City Hospital
University Conn Health Center
Doctors Specialties
- Neonatal Medicine
- Neonat/Perinatology
Accepted Insurances
Education
-
University of Connecticut -
Boston University Medical Center -
University of Vermont College of Medicine
Hospital
-
Boston Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Jonathan H. Cronin, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sadath A. Sayeed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Aimee C. Knorr, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Xianhua Piao, BM
This Doctor is OpenDoctor Recommended.
|
|
|
Michael Prendergast, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Padmaja R. Itikala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fu-Sheng Chou, MD |
|
|
Dr. Pankaj B. Agrawal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sule Cataltepe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Camilia R. Martin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard B. Parad, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul H. Lerou, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William D. Cochran, MD |
|
|
Dr. Katherine A. Sparger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan M. Davis, MD |
|
|
Dr. Paige T. Church, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Natalia Henner, MD
This Doctor is OpenDoctor Recommended.
|